Since 1982 the Association has raised over £10 million towards research projects in the UK investigating Raynaud's and scleroderma.
Grant application forms are available for download from - Applying for a Grant.
In line with other UK funding bodies, the Trustees have decided that grants will no longer be accepted from outside the UK.
Active Grants
University of Leeds (Chapel Allerton Hospital)
Dr Maya H Buch
A novel, longitudinal study of cardiac electrophysiological and structural changes in patients with systemic sclerosis - 3 year project
£75,000.00
Newcastle University, Newcastle upon Tyne
Thomas Hügle, Andreas Gessner, Jacob M. van Laar
Functional analysis of Tumor Necrosis Factor-alpha Receptor 1 and 2 in mononuclear cells in Systemic Sclerosis - Two year project £85,689.00
Addenbrookes Hospital, Cambridge
Dr Frances Hall
Assessment of Hand Ischaemia Outcome Measures in Patients with Systemic Sclerosis - 6 months
Royal National Hospital for Rheumatic Diseases, Bath
Prof Neil McHugh
Characterisation of novel autoantigen fragmentation following cell death in patients with Scleroderma and Raynaud’s phenomenon. £111,788
Dr John Pauling and Prof Neil McHugh
Dando Fellowship - Evaluation of the clinical, microvascular imaging and serum biomarker response to antithrombotic agents in Raynaud's phenomenon and scleroderma-spectrum disorders.
2 year project - £152,099
King's College London
Dr Sarah Howat
Does endoglin modulate the angiogenic switch of TGF-beta signalling in Systemic Sclerosis? - One year project £63,522.00
Hope Hospital, Manchester
Dr Ariane Herrick
Digital ulcers in systemic sclerosis - 2 year project - £55,020
Dr Ariane Herrick
Dando Fellowship - Cutaneous Telangiectases in Systemic Sclerosis - 21 months - £66,001
Part-Time Funding of an F Grade Nurse Specialist. This funding has been extended for a further 2 years.
The University of Manchester
Drs Herrick, Roberts, Murray, Anderson, Prof Taylor
Nailfold Capillaroscopy - Validation of its use as a clinical tool, further exploration of its use as a research tool. 2.5 years Project - £158,654
Royal Free Hospital, London
Prof D Abraham
Role of connective tissue growth factor in scleroderma - 3 year project
Total amount of the award is £178,958.25 - 50% RSA/50% Welton Foundation
Prof D Abraham
Pathogenesis and Clinical Manifestations of Pulmonary Fibrosis in scleroderma.
Joint 3 year project with the Royal Brompton Hospital. £241,214
Prof Christopher P Denton & Dr Voon H Ong
Exploration of the role of interleukin-6 in systemic sclerosis: differential expression and the potential role of IL-6 in determining clinical outcome in active SSc - 2 year project. £95,668.00
Dr Benjamin E Schreiber - Interplay between Interstitial Lung Disease and Pulmonary Hypertension in Prognosis and Response to Treatment of Patients with Systemic Sclerosis -1 year project. £51,378.00.
Royal Brompton Hospital, London
Prof Athol Wells
Pathogenesis and Clinical Manifestations of Pulmonary Fibrosis in scleroderma.
Joint 3 year project with Royal Free Hospital. £240,789
Completed Grants 2005 - 2011
UCL, London
Prof Alistair Forbes
Understanding intestinal functions, malnutrition, anorectal function and faecal incontinence in Systemic Sclerosis £181,480 End date 2009
Ulster Hospital, Belfast
Dr A E Smyth/Audrey Hamilton
Extension of Raynaud’s and Scleroderma Nurse Specialist funding
2 year extension End date 2009
Royal Free Hospital, London
Dr Richard Stratton
Role of the Epidermis in Scleroderma Fibrosis 2 year project
£55,894.00 End date 2009
Ninewells Hospital, Dundee
Prof Jill Belch
Cardiovascular events and mortality in SSc: A Study of the effect of iloprost on these and on disease progression
£632,759.00 End date 2008
Royal Brompton Hospital, London
Du Bois/Black
Gene and Protein Profiling in Systemic Sclerosis - Two Year EXTENSION
£139,678.00 End date 2008
Imperial College, London
Dr G Bou-Gharios, Prof C Black , Prof D Abraham
Preventing Tissue Fibrosis in scleroderma - 2 Year project
£98,757.00 End date 2008
Royal Free Hospital, London
Carol Black/Professor Du Bois
Gene and Protein Profiling in Systemic Sclerosis - Two Year EXTENSION
£152,050.00 End date 2008
Royal Free Hospital, London
Prof C Black /Prof D Abraham
Identificationof transcription factors involved in the over-expression of pro-fibrotic genes in Scleroderma 4 year project
£196,405.00 End date 2008
Manchester University
Dr Maria Jeziorska
A common mechanism to explain dermal and intraepidermal Tissue changes in patients with scleroderma.(2 Yr project)
£121,386.85 End date 2008
Manchester University
Professor Alan Silman
The Incidence of Scleroderma in Childhood
£72,038.00 End date 2008
University of Westminster
Dr Mark Eastwood/Prof David Abraham/Dr Catherine Sarraf
Biomechanical stimulation of fibroblasts in scleroderma 2 Year Project
£99,482.00 End date 2008
Bath University
Dr Neil McHugh
Autoantigen Proteome in Scleroderma
£126,000.00 End date 2007
Royal Free Hospital, London
Dr Patricia Garcia
Ozone production by fibroblasts,monocytes and neutrophils from Scleroderma patients. (18 mth project) £99,644.00 End date 2007
Hope Hospital, Manchester
Dr Arianne Herrick
A prospective study of changes in nailfold capillary architecture with time. (3 years)
£33,150.00 End date 2007
Birmingham, The Medical School
Prof Janice Marshall
Mechanisms underlying Primary Raynaud’s
£65,062.00 End date 2006
Imperial College, London
Dr Rachel Hoyles, Dr Athol Wells, Prof Chris Denton
Interaction between systemic disease, alveolar epithelial dysfunction and pulmonary fibrosis in scleroderma (1 Year)
£52,916.00 End date 2006
Royal Free Hospital, London
Prof Carol Black
The Role of the Fibroblast CTGF Receptor Syndecan-4 in Scleroderma (1 Year Project)
£56,483.00 End date 2006
Alder Hey Hospital, Liverpool
Dr Joyce Davidson
Autoantibodies in Juvenile scleroderma, myositis and overlap syndromes.
(Funding for the processing of samples for this project).
£ 8,849.00 End date 2005
Royal National Hospital for Rheumatic Diseases, Bath
Lindsay Shaw
Can Laser Doppler Skin Measurements Predict Clinical Progression of Linear Scleroderma? - A pilot project. £4,800.00 End date 2005
Belfast City Hospital
Dr Marshall Riley
Cardiac and Neurohumoral Abnormalities in Systemic Sclerosis
£90,892.12 End date 2005
Royal Brompton Hospital, London
Prof Athol Wells
DTPA clearance in systemic sclerosis: its pathogenetic significance & potential role as the optimal method of predicting outcome £100,825.00 End date 2005
Royal Brompton Hospital, London
Du Bois/Black
Gene and Protein Profiling in Systemic Sclerosis - Three years to fund studies into changes in gene and protein expression in systemic sclerosis and the development of a detailed SNP map of candidate genes. £197,305.00 End date 2005
Royal Free Hospital, London
Professor Carol Black/Dr Abraham
The role of TGF-b producing Th T cells in the immunopathogenesis of scleroderma.
£132,910.00 End date 2005
Royal Free Hospital, London
Profesor Carol Black
Monocyte chemoattractant protein-3 in systemic sclerosis
£96,695.00 End date 2005
Royal Free Hospital, London
Carol Black/Professor Du Bois
Gene and Protein Profiling in Systemic Sclerosis - Three years to fund studies into changes in gene and protein expression in systemic sclerosis and the development of a detailed SNP map of candidate genes. £215,291.00 End date 2005
